WUNDVERSCHLUSSSYSTEM MIT MEDIKAMENT

European patent · EP4586979 · In force

Register entry

Publication number
EP4586979
Application number
EP24775994
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 23, 2024
Published
Jul 23, 2025
Granted
May 13, 2026
Protection ends at the latest
Aug 22, 2044
Next annual fee due
Aug 31, 2027
IPC classes
A61F 13/00 (2024.01)
A61B 17/00 (2006.01)
A61F 13/02 (2024.01)
A61F 13/0246 (2024.01)
A61K 9/70 (2006.01)
A61L 15/44 (2006.01)
Priority
US 202318454270 23.08.2023
PCT application
PCT/IB2024/058219 23.08.2024
PCT publication
WO2025/041094 27.02.2025
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 5, 2026

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 05.06.2026

  2. May 13, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 13.05.2026

Parties

Inventor

OU, Duan Li

Raritan, New Jersey 08869, US

TANNHAUSER, Robert J.

Raritan, New Jersey 08869, US

KRIKSUNOV, Leo

Raritan, New Jersey 08869, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.